Cancer, Jerusalem Post, Dr Island Morad discussed on Sean Hannity


Fits that criteria that I've established that if something is too good to be true. It is too. Good to be true a meeting. It's that true. Nonetheless. The Jerusalem Post, which is a very credible. News organization. Is reporting that an Israeli company believes in his cured cancer. That this can't be right. Correct. The story is slow motion moving its way through. The media and getting more traction and more coverage. It showed up at the drudge report it's being covered at a number of business sites. And suddenly, it's all the rage and websites that are devoted to biotechnology. There's a small company called accelerated evolution biotechnologies. It was founded in two thousand and it's based in Israel. The scientists there say. Quote, we believe we will offer in a year's time a complete cure for cancer. Our cancer cure will be effective from day one. We'll ask the duration of a few weeks. We'll have no or minimal side effects at a much lower cost than most other treatments on the market. I solicit will be both generic and personal. No as the Jerusalem Post points out. This sounds crazy. Yes. It does sound crazy. The somewhere in Israeli company believes that it's cancer. But. The company claims that in its tasks which so far involves laboratory mice, and there are about to go into human testing that it's been foolproof. Quoting from the story. Dan, Meridor chairman of the board of AT and CEO Dr island Morad say their treatment, which they call Muto multi target toxin is essentially on the scale of a cancer, antibiotic a disruption technology of the highest order. The potentially game changing anticancer drug is based on SOAP technology which belongs to the display group of technologies. It involves the sounds complicated. It's not it involves the introduction of DNA coding for a protein such as an antibody into a bacteria page a virus that infects bacteria. The protein is then displayed on the surface of the researchers then use these protein displaying pages to screen for interactions with other proteins DNA sequences in small molecules in other words, what they think they can do a screw up the cancer cells in two thousand eighteen team of scientists won the Nobel prize for their work unfazed display in the directed. Evolution of new protein. Teens in particular for the production of antibody therapeutics eighty BI is doing something similar, but with peptides compounds of tour more amino acids linked to the chain, according to more at peptides have several advantages over antibodies, including the fair smaller cheaper and easier to produce and regulate when the company first started Morad said we were doing what everybody else is doing try to discover individual novel peptide specific cancers, but shortly thereafter, more and his colleague, Dr Hanan sake decided they wanted to do something bigger to get started. They said they had to identify other cancer killing drugs and treatments don't work or eventually fail. Then they found a way to counter that effect for starters, most anticancer drugs attack a specific target honor in the cancer. So inhibiting the target usually affects a physiological pathway that promotes cancer mutations of the targets are downstream and their physiological pathways could make the targets not relevant to the cancer each of the cell, and hence the drug attacking it is rendering rendered ineffective in contrast. Motto is using a combination of several cancer targeting targeting peptides, for each cancer cell at the same time combined with a strong peptide toxin that would kill cancer cells specifically by using at least three targeting peptides on the same structure with a strong toxin more ad said, quote, we made sure that the treatment will not be affected by mutations. Cancer cells can mutated in such a way the targeted receptors at dropped by the cancer. The story goes on and gets rather technical. He explained that. Because cancer cells are born out of you taste that occur in cancer stem cells, most of the overexposed proteins, which are targeted on the cancer cell exists in the cancer stem cells Buddha toes, multiple target attack insurance that they will be destroyed. As well. More. Add said, the discovery could also reduce the sickening side effects of most cancer treatments, which stemmed from drug treatments interacting with the wrong or additional targets are the correct targets. But on nine cancer cells. He says motor does combine having a combination of several highly specific cancer targeting peptides on one scaffold for each type of cancer cell would increase the specificity of the cancer cell due to the avidity effect. I know this sounds convoluted. But as I said if there's any chance this company has figured something out. It would be the biggest story of. I'd say the last century in a in global health care. I doubt it's true. It probably can't be true. The company does say, however, that they are ready to go to human testing that it has been one hundred percent effective when used with laboratory animals ended the models that they've created. They see no reason that it wouldn't be effective with human beings. The story is getting Craxton, and it's out there if you wanna look into it the name of the company again is accelerated evolution biotechnologies. I'm sure that once the mainstream media picks up on some of the trickles of this. There'll be some talk of it in some focus on it. And so I think most people believe that anything significant that happens in cancer will have to be done by one of the major drug companies because if anybody was close, what are the giant pharmaceuticals would immediately pay a fortune to buy that company out this particular company. Accelerated evolution biotechnologies is not publicly traded because it's privately traded. They don't have any shot. Shareholder fraud that they can worry about it. Maybe they're overstating things. Anyway. The stories out there. Let me go to another fascinating story. This is what I predicted. You're seeing something that was only percolating before beginning to come to the surface. It's another example of when we start inventing rights for someone how they come into conflict with someone else's rights in this instance. Different groups that are part of the same movement that have been lumped together. And it's beginning to dawn on some of the people in the group that other people in that group that are being lumped together with them don't have the same focus. Cutting through all of that a number of lesbians are very concerned about the transgender rights movement. They claim it's anti lesbian. They claim. It's a men's right movement. Now, I made the survey on the show better than a year ago that all of this suggestion that we need to start creating special rights for transgender individuals, and we start to accommodate people redefining their gender to be whatever that they wanted to be. Is going to come into total conflict with people who have been advocating for gay rights. You're starting to see this prominent lesbian feminists are saying we should not be accommodating allowing women who are lesbians to be able to sudden they claim that they're mad think about that. For a moment. If a woman who has been identifying as a lesbian, suddenly redefines herself to be a himself and a man will then she is now he therefore no longer a lesbian. And if she is now, a, hey, she isn't interested in women's rights, which of course, is the obsession with feminists. There's a story on this one on PJ media CARA Danske, a feminist lawyer and spokesman for the women's Liberation Front. Spoke against the so-called equality act. At the Heritage Foundation on Monday, denouncing the transgender and gender identity. Movement is anti women anti lesbian in particular. Her remarks echoed the London pride March signed declaring the transact of ISM erases lesbians. Quote, this is a men's rights movement. This really is a men's rights movement Danske declared calling for men to stand up for women and denounce the transgender movement. Those fascinating stuff in a world has gone completely weird. We're we're allowing people to identify and call themselves whatever they want to call themselves without any regard to what their biology would indicate. You.

Coming up next